Literature DB >> 25415510

A modular Geant4 model of Leksell Gamma Knife Perfexion™.

J Pipek1, J Novotný, J Novotný, P Kozubíková.   

Abstract

This work presents a Monte Carlo model of Leksell Gamma Knife Perfexion as well as the main parameters of the dose distribution in the standard phantom obtained using this model. The model is developed in the Geant4 simulation toolkit in a modular way which enables its reuse in other Perfexion studies. Large phase space files were created, containing particles that are entering the inner machine cavity after being transported through the collimation system. All 14 output factors of the machine and effective output factors for both the 4 mm (0.830 ± 0.009) and 8 mm (0.921 ± 0.004) collimators were calculated. Dose profiles along the main axes are also included for each collimator size. All results are compared to the values obtained from the treatment planning system, from experiments, and from other Monte Carlo models.

Mesh:

Year:  2014        PMID: 25415510     DOI: 10.1088/0031-9155/59/24/7609

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  3 in total

Review 1.  Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues.

Authors:  Arjun Sahgal; Mark Ruschin; Lijun Ma; Wilko Verbakel; David Larson; Paul D Brown
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

2.  Monte Carlo Dose Calculation Using MRI Based Synthetic CT Generated by Fully Convolutional Neural Network for Gamma Knife Radiosurgery.

Authors:  Jiankui Yuan; Elisha Fredman; Jian-Yue Jin; Serah Choi; David Mansur; Andrew Sloan; Mitchell Machtay; Yiran Zheng
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

3.  Development of a Monte Carlo model for treatment planning dose verification of the Leksell Gamma Knife Perfexion radiosurgery system.

Authors:  Jiankui Yuan; Simon S Lo; Yiran Zheng; Jason W Sohn; Andrew E Sloan; Rodney Ellis; Mitchell Machtay; Barry Wessels
Journal:  J Appl Clin Med Phys       Date:  2016-07-08       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.